{"id":413719,"date":"2021-01-13T02:03:27","date_gmt":"2021-01-13T07:03:27","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=413719"},"modified":"2021-01-13T02:03:27","modified_gmt":"2021-01-13T07:03:27","slug":"tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\/","title":{"rendered":"Tiziana announces appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK and LONDON, Jan.  13, 2021  (GLOBE NEWSWIRE) &#8212; Tiziana Life Sciences plc (Nasdaq: TLSA \/ AIM: TILS) (\u201cTiziana\u201d or the \u201cCompany\u201d), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, announces the appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer.<\/p>\n<p align=\"justify\">Dr Graham is a medicines development expert and Infectious Diseases Epidemiologist with global Biotech and Pharma R&amp;D experience in Phase I-IV therapeutics as well as <em>in-vivo &amp; in-vitro<\/em> diagnostics, across many modalities. He has in depth Global Development Expertise (e.g. Virology, Respiratory, Dermatology, Allergy, &amp; Rheumatology) in early &amp; late stage Clinical Development and in Medical Affairs, with a strong track record for Developing and Accelerating Phase I\u2013IV programs. Multiple IND\u2019s, NDA\/BLA filings and\/or defense and multiple successful launches.<\/p>\n<p align=\"justify\">From 2010 to 2020, Dr Graham was VP of Strategic Program Direction, Immunology and Inflammation at Regeneron Pharmaceuticals, Inc., where he managed and oversaw a large portion of the Regeneron pipeline portfolio including leading the immunology and inflammation antibody products across all stages of development from preclinical to post-launch. He was instrumental in the development of DUPIXENT (dupilumab), a blockbuster monoclonal antibody, from Phase 1 through its initial launch for atopic dermatitis, as well as expanding its development into asthma, sinusitis, and eight other indications. During his tenure at Regeneron, Dr. Graham also led the product development for KEVZARA (sarilumab), an IL-6R antibody for rheumatoid arthritis, and REGN3500, an anti-IL33 antibody for asthma and COPD. As part of this role he built innovative, high-performing development teams and managed the Regeneron\u2019s regulatory filings, interactions with regulatory agencies, product launches, and business development and licensing activities across its product portfolio.<\/p>\n<p align=\"justify\">Prior to Regeneron, Dr. Graham served as Senior Vice President, Program and Portfolio Management at Vertex, where he oversaw the team of program leaders and managers across the portfolio from Phase 1 through launch, including Telaprevir for hepatitis C (HCV), and two innovative product candidates for cystic fibrosis which are now on the market. Previously, he held roles as CMO at Trimeris Inc. and XTL Biopharmaceuticals and worked in HIV Medical Affairs at Glaxo Welcome. Earlier in his career, Dr. Graham was an Associate Professor of Medicine and Epidemiology at John Hopkins University, School of Hygiene and Public Health. He is the author of five chapters and books and more than 140 peer-reviewed journal articles. Dr. Graham earned an M.D., M.B.B.S., and M.P.H. from the University of Adelaide in Australia.\u00a0<\/p>\n<p align=\"justify\">Dr. Graham stated: \u201cI am excited to join Tiziana to help develop its unique monoclonal antibody platform for autoimmune diseases. Tiziana\u2019s ability to deliver antibody immunotherapeutics via oral and nasal routes is a potential game-changer for patients and physicians alike.\u201d<\/p>\n<p align=\"justify\">Kunwar Shailubhai, CEO of Tiziana said: \u201cWe are very excited about Dr. Graham\u2019s addition to the Tiziana team. Dr Graham\u2019s invaluable experience at Regeneron and Vertex in different disciplines is a great fit for the Tiziana pipeline.\u201d<\/p>\n<p align=\"justify\">\u201cWe are delighted to have Dr. Graham join the Tiziana team. His knowledge and experience at Regeneron in developing blockbuster monoclonal antibody drugs such as Dupixent will be invaluable in developing Foralumab and our anti IL-6Drug, TZLS-501,\u201d said Chairman and Founder Gabriele Cerrone<\/p>\n<p>\n        <strong>THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION (EU) NO 596\/2014<\/strong>\n      <\/p>\n<p>\n        <strong>About Tiziana Life Sciences<\/strong><br \/>\n        \n      <\/p>\n<p align=\"justify\">Tiziana Life Sciences plc is a dual listed (NASDAQ: TLSA &amp; UK AIMS: TILS) biotechnology company that focuses on the discovery and development of novel molecules to treat human diseases in oncology, inflammation and infectious diseases. In addition to milciclib, the Company will be shortly initiating Phase 2 studies with orally administered Foralumab for Crohn\u2019s Disease and nasally administered Foralumab for progressive multiple sclerosis. Foralumab is the only fully human anti-CD3 monoclonal antibody (mAb) in clinical development in the world. This Phase 2 compound has potential application in a wide range of autoimmune and inflammatory diseases, such as Crohn\u2019s Disease, multiple sclerosis, type-1 diabetes (T1D), inflammatory bowel disease (IBD), psoriasis and rheumatoid arthritis, where modulation of a T-cell response is desirable. The company is accelerating development of anti-Interleukin 6 receptor (IL6R) mAb, a fully human monoclonal antibody for treatment of IL6-induced inflammation, especially for treatment of COVID-19 patients.<\/p>\n<p>\n        <strong>For further enquiries:<\/strong><br \/>\n        <br \/>\n        <strong>United Kingdom:<\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">\n            <strong>Tiziana Life Sciences plc<\/strong><br \/>\n            <br \/>Gabriele Cerrone, Chairman and founder\u00a0<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">+44 (0)20 7495 2379<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">\n            <strong>\u00a0<\/strong><br \/>\n            <br \/>\n            <strong>Cairn Financial Advisers LLP\u00a0(Nominated adviser)<\/strong><br \/>\n            <br \/>Liam Murray \/ Jo Turner<br \/>\u00a0<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<br \/>+44 (0)20 7213 0880<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">\n            <strong>Optiva Securities Limited (Broker)<\/strong><br \/>\n            <br \/>Robert Emmet<\/p>\n<p><strong>United States:<\/strong><br \/>Investors:<br \/>Dave Gentry, CEO<br \/>RedChip Companies Inc.<br \/>407-491-4498<br \/><a href=\"mailto:dave@redchip.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">dave@redchip.com<\/a><\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">+44 (0)20 3981 4173<\/td>\n<\/tr>\n<\/table>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNDY5MyMzOTE1ODc0IzIxMjM4ODU=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/3c8645f4-deac-4332-b18a-9b3381356d5e\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK and LONDON, Jan. 13, 2021 (GLOBE NEWSWIRE) &#8212; Tiziana Life Sciences plc (Nasdaq: TLSA \/ AIM: TILS) (\u201cTiziana\u201d or the \u201cCompany\u201d), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, announces the appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer. Dr Graham is a medicines development expert and Infectious Diseases Epidemiologist with global Biotech and Pharma R&amp;D experience in Phase I-IV therapeutics as well as in-vivo &amp; in-vitro diagnostics, across many modalities. He has in depth Global Development Expertise (e.g. Virology, Respiratory, Dermatology, Allergy, &amp; Rheumatology) in early &amp; late stage Clinical Development and in Medical Affairs, with a strong track record for Developing and Accelerating Phase I\u2013IV programs. Multiple &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Tiziana announces appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-413719","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tiziana announces appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tiziana announces appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK and LONDON, Jan. 13, 2021 (GLOBE NEWSWIRE) &#8212; Tiziana Life Sciences plc (Nasdaq: TLSA \/ AIM: TILS) (\u201cTiziana\u201d or the \u201cCompany\u201d), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, announces the appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer. Dr Graham is a medicines development expert and Infectious Diseases Epidemiologist with global Biotech and Pharma R&amp;D experience in Phase I-IV therapeutics as well as in-vivo &amp; in-vitro diagnostics, across many modalities. He has in depth Global Development Expertise (e.g. Virology, Respiratory, Dermatology, Allergy, &amp; Rheumatology) in early &amp; late stage Clinical Development and in Medical Affairs, with a strong track record for Developing and Accelerating Phase I\u2013IV programs. Multiple &hellip; Continue reading &quot;Tiziana announces appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-13T07:03:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNDY5MyMzOTE1ODc0IzIxMjM4ODU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Tiziana announces appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer\",\"datePublished\":\"2021-01-13T07:03:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\\\/\"},\"wordCount\":763,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNDY5MyMzOTE1ODc0IzIxMjM4ODU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\\\/\",\"name\":\"Tiziana announces appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNDY5MyMzOTE1ODc0IzIxMjM4ODU=\",\"datePublished\":\"2021-01-13T07:03:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNDY5MyMzOTE1ODc0IzIxMjM4ODU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNDY5MyMzOTE1ODc0IzIxMjM4ODU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tiziana announces appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tiziana announces appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\/","og_locale":"en_US","og_type":"article","og_title":"Tiziana announces appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer - Market Newsdesk","og_description":"NEW YORK and LONDON, Jan. 13, 2021 (GLOBE NEWSWIRE) &#8212; Tiziana Life Sciences plc (Nasdaq: TLSA \/ AIM: TILS) (\u201cTiziana\u201d or the \u201cCompany\u201d), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, announces the appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer. Dr Graham is a medicines development expert and Infectious Diseases Epidemiologist with global Biotech and Pharma R&amp;D experience in Phase I-IV therapeutics as well as in-vivo &amp; in-vitro diagnostics, across many modalities. He has in depth Global Development Expertise (e.g. Virology, Respiratory, Dermatology, Allergy, &amp; Rheumatology) in early &amp; late stage Clinical Development and in Medical Affairs, with a strong track record for Developing and Accelerating Phase I\u2013IV programs. Multiple &hellip; Continue reading \"Tiziana announces appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-13T07:03:27+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNDY5MyMzOTE1ODc0IzIxMjM4ODU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Tiziana announces appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer","datePublished":"2021-01-13T07:03:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\/"},"wordCount":763,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNDY5MyMzOTE1ODc0IzIxMjM4ODU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\/","name":"Tiziana announces appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNDY5MyMzOTE1ODc0IzIxMjM4ODU=","datePublished":"2021-01-13T07:03:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNDY5MyMzOTE1ODc0IzIxMjM4ODU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNDY5MyMzOTE1ODc0IzIxMjM4ODU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-announces-appointment-of-dr-neil-graham-mbbs-md-mph-as-chief-medical-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Tiziana announces appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/413719","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=413719"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/413719\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=413719"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=413719"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=413719"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}